SARAH LAKADAWALA: Open Payments
NPI 1144068750 · PALM HARBOR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$666 in 21 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $148 · 2025 $666
Food & beverage: $666
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $207 |
| ABBVIE INC. | 4 | $160 |
| REVANCE THERAPEUTICS, INC. | 2 | $92 |
| Galderma Laboratories, L.P. | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| CSL Behring | 2 | $38 |
| Grifols USA, LLC | 1 | $23 |
| Astellas Pharma US Inc | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Corcept Therapeutics | 1 | $16 |
Products named: BOTOX, BREZTRI, DAXXIFY, NUCALA, Xembify, FASENRA, Veozah, Haegarda.
Industry payments across FL — which companies pay providers there.
